 |
|
| HIV I: MOLECULAR BIOLOGY AND PATHOGENESIS: CLINICAL APPLICATIONS, 49
| |
| | |
|
|
To order this title, and for more information, click here
J. August, John Hopkins University; Department of Pharmacology, Baltimore, Maryland, U.S.A.
Kuan-Teh Jeang, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, U.S.A.
Ferid Murad, University of Texas Medical School, Houston, U.S.A.
Included in series
Advances in Pharmacology,
Description
The cumulative death toll from AIDS has reached 16.3 million individuals, and more than 33 million persons are currently living with HIV-1.
Although it is one of the most-widely studied viruses, many mysteries remain about this pathogen. In this comprehensive two-volume set, HIV-1: Molecular Biology and Pathogenesis, leading investigators in HIV research present a timely picture of the molecular
mechanisms which guide HIV-1 expression and replication and provide the most current clinical strategies for combating this virus. Twenty-six
teams of experts unravel structure-function interactions of HIV-1 with host cells and the resulting pathological consequences, review
strategies fo treatment, and describe ongoing progress in developing animal models and prophylactic vaccines.
The two volumes, covering
viral mechanisms and clinical applications, respectively, are written by an international collection of AIDS expers from North America,
Europe, Australia, and Asia.
Audience
Graduate students, postdoctoral fellows, and senior researchers in virology and pharmacology, as well as clinicians and clinical fellows in infectious diseases.
Contents
HIV Therapeutics: Past, Present, and Future, O. Abu-Ata, J. Slim, G. Perez, and S.M. Smith.
HIV Drug Resistance and Viral Fitness, F. Clavel and F. Mammano.
Inhibitors of HIV-1 Reverse Transcriptase, M.A. Parniak and N. Sluis-Cremer.
HIV-I Protease:
Maturation, Enzyme Specificity, and Drug Resistance, J.M. Louis, I.T. Weber, J. Tözsér, G.M. Clore, and A.M. Gronenborn.
HIV-I Integrase Inhibitors: Past, Present, and Future, N. Neamati, C. Marchand, and Y. Pommier.
Selection of HIV Replication
Inhibitors: Chemistry and Biology, S. Hwang, N. Tamilarasu, and T.M. Rana.
Therapies Directed against the Rev Axis of HIV Autoregulation, A.I. Dayton and M.J. Zhang.
HIV-I Gene Therapy: Promise for the Future, R. Dornburg and R.J. Pomerantz.
Assessment
of HIV Vaccine Development: Past, Present, and Future, M.W. Cho.
HIV-I-Associated Central Nervous System Dysfunction, F.C.
Krebs, H. Ross, J. McAllister, and B. Wigdahl.
Molecular Mechanisms of Human Immunodeficiency Virus Type I Mother-Infact Transmission, N. Ahmad.
Molecular Epidemiology of HIV-I: An Example of Asia, M.-Y. Chen and C.-N. Lee.
Simian Immunodeficiency Virus
Infection of Monkeys as a Model System for the Study of AIDS Pathogenesis, Treatment and Prevention, V.M. Hirsch and J.D. Lifson.
Animal Models for AIDS Pathogenesis, J.J. Trimble, J.R. Salkowitz, and H.W. Kestler.
Index.
Contents of Previous Volumes.
| Bibliographic details |
Hardbound, 568 pages, publication date: SEP-2000
ISBN-13: 978-0-12-032950-2
ISBN-10: 0-12-032950-6
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
GBP 135.99
USD 225
EUR 160.95
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/951
Last update: 3 Oct 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company